Departement for Orthopaedic Surgery, University Medical Centre of Cologne, Regensburg, Germany.
REPAIR-Lab, Institute of Pathology, University of Regensburg, Franz-Josef-Strauß Allee 11, 93053, Regensburg, Germany.
Knee Surg Sports Traumatol Arthrosc. 2021 Feb;29(2):417-421. doi: 10.1007/s00167-020-05976-9. Epub 2020 Apr 10.
Traumatic lesions of articular cartilage represent a crucial risk factor for osteoarthritis. Even if several strategies exist to treat such damages, the optimal solution has not yet been found. A new strategy represents the scaffold-free spheroid-based autologous chondrocyte transplantation. In this method, spheroids of chondrocytes are synthesized after chondrocyte isolation and expansion, followed by the implantation in a second intervention.
Fine Jamshidi-needle biopsies from five patients (one from each patient, Ø 2 mm) treated with a spheroid-based autologous chondrocyte implantation (ACI) after traumatic lesions of the articular cartilage of the knee were analysed histologically and immunohistologically for collagen II, collagen X and aggrecan expression. The indication for a second look arthroscopy was given by arthrofibrosis or meniscus-lesions, respectively. The time between ACI and second-look arthroscopy ranged between 6 and 16 months.
In all patients, the histological examinations revealed an avascular cartilage tissue with a homogenic extracellular matrix. The subchondral bone neither showed bleeding, necrosis nor hypertrophy. A homogenous alcian blue staining indicated high amounts of mucopolysaccharides and glycosaminoglycans. Collagen II staining was highly positive, whereas collagen X staining was negative in every patient, ruling out hypertrophic chondrocyte differentiation. In addition, intense aggrecan staining indicated a strong expression of this extracellular matrix component.
The present case series represents the first histological and immunohistological analyses of spheroid-based ACI in humans. Spheroid-based ACI revealed excellent histological results regarding the regeneration of hyaline articular cartilage. These results indicate that spheroid based ACI is a promising strategy for treating traumatic lesions of the articular cartilage of the knee.
关节软骨的创伤性损伤是骨关节炎的一个关键危险因素。尽管有几种策略可以治疗这种损伤,但尚未找到最佳解决方案。一种新的策略是无支架的球体自体软骨细胞移植。在这种方法中,在软骨细胞分离和扩增后合成球体,然后在第二次干预中植入。
对 5 名膝关节关节软骨创伤性损伤接受球体自体软骨细胞移植(ACI)治疗的患者进行精细 Jamshidi 针活检(每位患者一个,Ø 2mm),通过组织学和免疫组织化学分析 II 型胶原、X 型胶原和聚集蛋白聚糖的表达。进行第二次关节镜检查的指征分别为关节纤维化或半月板损伤。ACI 与第二次关节镜检查之间的时间间隔为 6 至 16 个月。
在所有患者中,组织学检查均显示出无血管的软骨组织,具有同质的细胞外基质。软骨下骨既没有出血、坏死也没有肥大。同质的阿尔辛蓝染色表明存在大量粘多糖和糖胺聚糖。所有患者的 II 型胶原染色均呈高度阳性,而 X 型胶原染色均呈阴性,排除了肥大软骨细胞分化。此外,强烈的聚集蛋白聚糖染色表明这种细胞外基质成分的表达很强。
本病例系列是首例关于球体 ACI 在人类中的组织学和免疫组织化学分析。球体 ACI 在再生透明关节软骨方面取得了极好的组织学结果。这些结果表明,球体 ACI 是治疗膝关节关节软骨创伤性损伤的一种很有前途的策略。